PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Hard-to-Treat brain cancer
Disease control CompletedThis early-phase trial tested a combination of three drugs (ibrutinib, rituximab, and lenalidomide) in 25 adults with recurrent or treatment-resistant central nervous system lymphoma. The main goal was to find the safest dose of ibrutinib when given with the other two drugs. Rese…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Can a cancer drug stop brain lymphoma from coming back?
Disease control CompletedThis study tested the drug nivolumab in people with primary central nervous system lymphoma (PCNSL) whose spinal fluid still showed signs of tumor DNA after their first round of chemotherapy. The goal was to see if nivolumab could safely prevent the cancer from returning. Fourtee…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC